Taking people in LebanonNo phase
Studies chronic myeloid leukemia in children and adolescents
Describes chronic myeloid leukemia and its treatment in young patients under 18.
Key facts
- Who runs it
- Poitiers University Hospital
- Where
- Beirut, LebanonSee the siteAlso in 19 other countries, 19 sites
- Trial code
- Registry title
- International Chronic Myeloid Leukemia Pediatric Study
- Status
- Recruiting
- People taking part
- 750 people, planned
- Started
- Jan 2011
- Expected to end
- Dec 2028
- Type of study
- Observational
- Record updated
- 17 January 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teenagers under 18 with Philadelphia positive and/or BCR-ABL positive chronic myeloid leukemia (CML), in any phase.
- Age
- Younger than 18 years.
- Sex
- Boys and girls can both join.
- Disease stage
- Chronic myeloid leukemia (CML) in all phases.
- Biomarker or test result
- Philadelphia positive and/or BCR-ABL positive.
Main reasons for not taking part
- People who were more than 18 years old when CML was diagnosed cannot join.
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- patients less than 18 years of age
- diagnosed Philadelphia positive and/or BCR-ABL positive Chronic Myeloid Leukemia (CML) all phases
Who cannot take part
- patients more than 18 years of age at diagnosis of CML
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- How old is the patient who may join a trial?
- What type of cancer has the patient been diagnosed with?
Where in Lebanon
Also in 19 other countries, 19 sites
- Saint George Hospital University Medical CentreBeirut, LebanonContact: Farah ROULA, MDTaking people
About the trial
What the trial wants to find out
The purpose of the study is to describe and characterize CML in a large pediatric cohort of patients.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- INTERNATIONAL STUDY of Chronic Myeloid Leukaemia (CML) Treatment and Outcomes in Children and Adolescents
- Plain-language title
- Studies chronic myeloid leukemia in children and adolescentsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT01281735, who can take part
- Record updated
- 17 January 2024